AH
Amjad Husain
About Amjad Husain
Data last updated:
Amjad Husain is a Director at Canfinis Therapeutics Private Limited (since 2021) and Director at Ulo Labs Private Limited (since 2024). The companies operate in Healthcare and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹23.7 Lakh; the largest is Canfinis Therapeutics Private Limited at ₹23.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jul 2021 | 2021 | ₹23.7 Lakh (FY 2025) | Active | |
| Director | 26 Jun 2024 | 2024 | ₹5,170 (FY 2025) | Active |
Board colleagues of Amjad Husain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandra Chur Ghosh | 09466886 | Canfinis Therapeutics Private Limited | Director |
| Pradip Kumar Majumder | 02985222 | Canfinis Therapeutics Private Limited | Director |
| Udeep Chawla | 10683743 | Ulo Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amjad Husain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amjad Husain
Amjad Husain currently holds 2 directorships: Canfinis Therapeutics Private Limited (Director, since 30 Jul 2021, revenue ₹23.7 Lakh (FY 2025)); Ulo Labs Private Limited (Director, since 26 Jun 2024, revenue ₹5,170 (FY 2025)).
Amjad Husain was first appointed on 30 Jul 2021 as Director at Canfinis Therapeutics Private Limited. The most recent appointment on record is 26 Jun 2024 at Ulo Labs Private Limited.
The 2 current companies of Amjad Husain that report revenue have a combined latest revenue of ₹23.7 Lakh: Canfinis Therapeutics Private Limited ₹23.7 Lakh (FY 2025); Ulo Labs Private Limited ₹5,170 (FY 2025).
The current boards of Amjad Husain's companies include Chandra Chur Ghosh (Canfinis Therapeutics Private Limited), Pradip Kumar Majumder (Canfinis Therapeutics Private Limited), Udeep Chawla (Ulo Labs Private Limited).